Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07132684) titled 'Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients' on Aug. 13.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Condition:
AML, Adult
Intervention:
Drug: Daunorubicin/Idarubicin
Drug: Cytarabine
Drug: Azacitidine
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: August 30, 2025
Target Sample Size: 240
To know more, visit https://clinicaltrials.gov/ct2/...